VerImmune Inc. Raises $4.5 Million in PreSeries A Funding Round
| | |

VerImmune Inc. Raises $4.5 Million in PreSeries A Funding Round

ByAlice Temper

VerImmune Inc., a biotechnology company, has successfully closed a $4.5 million PreSeries A financing round. The funding will be utilized to advance the development of their lead product candidate, VERI101, towards clinical trials. VERI101 is a Firstinclass cancer immunotherapy leveraging the Virusinspired Particle (ViP) technology to redirect preexisting immune memory from CMV infection towards tumors for destruction. Leading the funding round was Beiley Biofund, with new investor Dr. John Ballantyne and returning investors Proxima Ventures, Mana Ventures, Gaingels, among others, participating. The addition of Dr. Che Hsu and Dr. Marta New to VerImmunes Board of Directors, along with their expertise in novel modalities and product development, aims to strengthen strategic guidance and drive clinical and commercial success for the company.

Article

Similar Posts

Moondance Labs Announces $6M Funding to Boost Development of Tanssi Protocol
|

Moondance Labs Announces $6M Funding to Boost Development of Tanssi Protocol

ByAlice Temper

Moondance Labs, the creators of the innovative Tanssi appchain infrastructure protocol, have successfully secured a $6 million funding round. The funds will be used for team expansion at Moondance Labs and further refining the Tanssi protocol. Tanssi aims to enhance appchain deployment efficiency for developers, offering tools to facilitate quick and effective chain launches. The…

Impact Analytics Secures $40 Million in Growth Financing
| | |

Impact Analytics Secures $40 Million in Growth Financing

ByAlice Temper

Impact Analytics, a provider of innovative planning and merchandising software suite for retail, grocery, CPG, and supply chain industries, has announced the closure of a $40 million growth financing round. The funding will be used to expand the company’s sales, marketing, and customer service organizations in the U.S. and abroad, ensuring that its technology platform…

Science Exchange Acquired by Waud Capital Partners to Accelerate Growth in Life Sciences Procurement Solutions
| | |

Science Exchange Acquired by Waud Capital Partners to Accelerate Growth in Life Sciences Procurement Solutions

ByAlice Temper

Science Exchange, a provider of life sciences procurement and supplier management SaaS solutions, has been acquired by Waud Capital Partners, a private equity firm specializing in the software & technology and healthcare sectors. The acquisition aims to further enhance Science Exchanges innovative cloud supplier orchestration platform for the life sciences industry. The partnership with Waud…

Blitzy Raises $4.4M in Initial Capital to Revolutionize Custom Software Development
|

Blitzy Raises $4.4M in Initial Capital to Revolutionize Custom Software Development

ByAlice Temper

Blitzy, a GenAI company founded by NVIDIA Serial Inventor Sid Pardeshi and Serial Entrepreneur Brian Elliott, is focused on automating endtoend custom software development. The companys platform utilizes a proprietary orchestration platform to automate large portions of the software development process, with the ultimate goal of achieving full autonomy. Blitzy has recently emerged from stealth…

LOST iN Acquires BuzzFeeds Bring Me! to Expand Travel Content Reach
| | |

LOST iN Acquires BuzzFeeds Bring Me! to Expand Travel Content Reach

ByAlice T

LOST iN, a media brand focused on inspiring travel enthusiasts, has acquired BuzzFeeds Bring Me!, a prominent travel and experience publisher. The acquisition aims to enhance LOST iNs content library and broaden its audience reach globally. The purchase is part of LOST iNs strategy to provide valuable content and engagement to its community. LOST iN,…

Leave a Reply

Your email address will not be published. Required fields are marked *